Mechanism · Research Data · Evidence Limits · Compound Information
RU58841 and GHK-Cu are discussed together because they target different parts of the hair-loss theory: androgen signalling and the surrounding tissue environment. Each compound has separate preclinical research, but the pair has not been tested together in a dedicated clinical trial. RU58841 does not have large-scale human hair-loss trials, and the page itself notes an evidence gap around direct GHK-Cu hair-follicle claims. This is a mechanism-based research idea, not a validated treatment protocol.
RU58841 has been studied as an androgen receptor antagonist in preclinical hair models. GHK-Cu has separate laboratory and topical skin research. Evidence on each compound does not demonstrate that combining them improves hair growth or is safe.
A non-steroidal topical antiandrogen, studied as a competitive androgen receptor antagonist acting locally at the scalp. Ex vivo scalp graft research and primate model studies have reported increased hair growth rates and follicle recycling with topical application, with no systemic hormonal effects detected in the primate research model. Full detail in the RU58841 Research Guide.
A naturally occurring copper-binding peptide studied for collagen synthesis in fibroblast culture. The cited paper does not study hair follicles. Full detail and evidence limits are in the GHK-Cu Research Guide.
| Compound | Research Model | Reported Effect |
|---|---|---|
| RU58841 | Human balding scalp grafts (nude mouse model) | Higher rate of follicles re-entering a second hair cycle; increased linear hair growth rate vs control. |
| RU58841 | Stump-tailed macaque model | Increased hair density, thickness, and length; no detected systemic effects. |
| GHK-Cu | Fibroblast culture | Increased collagen synthesis without changing cell number. This was not a hair-follicle study. |
Hair loss research is genuinely complex, and androgenetic alopecia has multiple contributing factors beyond DHT sensitivity and tissue health. Neither RU58841 nor GHK-Cu has completed large-scale human clinical trials for hair loss specifically. This guide exists to explain the mechanisms clearly, not to suggest either compound — alone or combined — is a guaranteed solution.
Note: AHK-Cu, a structurally related copper tripeptide sometimes discussed in the same hair-health context as these compounds, is a different compound from GHK-Cu and is not part of the pairing covered on this page. See the separate AHK-Cu Research Guide for its own, considerably thinner, evidence base.
More evidence-based peptide research guides, free.
Browse the Research GuidesTracking food too? Calorie counter with barcode scanner →
